Not All Drugs on Market Have FDA Approval
Posted on: Monday, 18 September 2006, 15:00 CDT
The Washington-based U.S. Food and Drug Administration is warning consumers that some 2 percent of prescription drugs on the market lack FDA approval.
Not only are the drugs untested for their effectiveness, but they might actually be harmful, USA Today reports.
Many of these drugs contain unapproved active ingredients that been on the market prior to 1962 when an amendment to the Food, Drug and Cosmetic Act required that all medication had to be proven effective.
We have concerns about their safety, about their quality, about their labeling, said Deborah Autor, FDA's director of compliance.
Because the agency doesn't have the resources to get all of these drugs off the market, it is targeting the ones it considers most dangerous.
The makers of these drugs say their medications must be safe and effective because doctors keep prescribing them.
Physicians and pharmacists are often unaware of the drugs' approval status since they are listed in the Physician's Desk Reference and advertised in medical journals.
Source: United Press International
Related Articles
- New Drugs From Novartis and Daiichi Sankyo Will Achieve Blockbuster Status in the Hypertension Drug Market
- Restless Legs Syndrome Drug Market Will Exceed $1 Billion in 2015
- Evaluate the New Developments That Are Driving the World's Bulk Drugs Market
- Next Generation of HIV Antiretrovirals Will Help Drive the HIV Drug Market to More Than $10 Billion in 2015
- By 2020, the Population Aged 65 or Older in the United States is Projected to Reach 55 Million (16.3% of the Overall U.S. Population) a Good Demographic for the Geriatric Drug Market
- The Global Drug Market for Dermatological Conditions Associated With Ageing and Lifestyle Was Estimated at US$1.8 Billion in 2005
- Woman Sentenced In Cocaine Sting: Bar Described As 'Open-Air Drug Market'
- The Global Drug Market for Dermatological Conditions Associated With Ageing and Lifestyle is Estimated at US$1.8 Billion in 2005
- Research and Markets: Worldwide Prescription Drug Market for Women's Health Forecast to Grow to $11.6 Billion in 2009
- Crohn's Disease Drug Market to Experience Dynamic Growth of 73% By 2013
User Comments (0)

RSS Feeds